Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

María F. Mercogliano, Gloria Inurrigarro, Mara De Martino, Leandro Venturutti, Martín A. Rivas, Rosalía Cordo-Russo, Cecilia J. Proietti, Elmer A. Fernández, Isabel Frahm, Sabrina Barchuk, Daniel H. Allemand, Silvina Figurelli, Ernesto Gil Deza, Sandra Ares, Felipe G. Gercovich, Eduardo Cortese, Matías Amasino, Pablo Guzmán, Juan C. Roa, Patricia V. Elizalde, Roxana Schillaci

Open source

DOI: 10.1186/s12885-017-3897-x
Published: 2017-12
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-017-3897-x,
  title = {Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer},
  author = {María F. Mercogliano and Gloria Inurrigarro and Mara De Martino and Leandro Venturutti and Martín A. Rivas and Rosalía Cordo-Russo and Cecilia J. Proietti and Elmer A. Fernández and Isabel Frahm and Sabrina Barchuk and Daniel H. Allemand and Silvina Figurelli and Ernesto Gil Deza and Sandra Ares and Felipe G. Gercovich and Eduardo Cortese and Matías Amasino and Pablo Guzmán and Juan C. Roa and Patricia V. Elizalde and Roxana Schillaci},
  year = {2017},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-017-3897-x},
  url = {https://doi.org/10.1186/s12885-017-3897-x}
}

RIS

TY  - JOUR
TI  - Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer
AU  - María F. Mercogliano
AU  - Gloria Inurrigarro
AU  - Mara De Martino
AU  - Leandro Venturutti
AU  - Martín A. Rivas
AU  - Rosalía Cordo-Russo
AU  - Cecilia J. Proietti
AU  - Elmer A. Fernández
AU  - Isabel Frahm
AU  - Sabrina Barchuk
AU  - Daniel H. Allemand
AU  - Silvina Figurelli
AU  - Ernesto Gil Deza
AU  - Sandra Ares
AU  - Felipe G. Gercovich
AU  - Eduardo Cortese
AU  - Matías Amasino
AU  - Pablo Guzmán
AU  - Juan C. Roa
AU  - Patricia V. Elizalde
AU  - Roxana Schillaci
PY  - 2017
JO  - BMC Cancer
DO  - 10.1186/s12885-017-3897-x
UR  - https://doi.org/10.1186/s12885-017-3897-x
ER  -

APA

Mercogliano, M. F., Inurrigarro, G., Martino, M. D., Venturutti, L., Rivas, M. A., Cordo-Russo, R., Proietti, C. J., Fernández, E. A., Frahm, I., Barchuk, S., Allemand, D. H., Figurelli, S., Deza, E. G., Ares, S., Gercovich, F. G., Cortese, E., Amasino, M., Guzmán, P., Roa, J. C., Elizalde, P. V., & Schillaci, R. (2017). Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer. BMC Cancer. https://doi.org/10.1186/s12885-017-3897-x

Source records

crossref · retrieved 2026-09-26T10:13:05.567Z